NEW YORK (GenomeWeb) – Clinical Genomics recently presented new data that demonstrate that its two-gene blood test for post-surgical monitoring of colorectal cancer recurrence is nearly three times more effective at picking up recurrence than measuring antigen levels, the only other monitoring tool on the market.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.